Skip to main content
. 2021 Nov 26;24(5):781–793. doi: 10.1093/neuonc/noab275

Table 1 .

Clinical, Radiological, and Histopathological Characteristics of the Patients’ Sample

Total patients
Mean (SD) or %
Demographics
Age 39.08 (10.49)
Mean education in years 14.45 (3.08)
Gender H/F, n (%) 85 (54.14%)/72 (45.86.0%)
Right-handed, n (%) 130 (83.0%)
Left-handed, n (%) 16 (10.0%)
Ambidextrous, n (%) 11 (7.0%)
Tumor location
Left, n (%) 78 (49.68%)
Right, n (%) 79 (50.32%)
Frontal, n (%) 94 (59.99%)
FTI, n (%) 34 (21.66%)
F, n (%) 25 (15.92%)
SMA, n (%) 9 (5.73%)
Premotor, n (%) 13 (8.28%)
Fronto-insular (Predom. F). n (%) 13 (8.28%)
Temporal 36 (22.92%)
Temporal, n (%) 17 (10.83%)
Temporo-insular (Predom, T), n (%) 12 (7.64%)
Temporal (posterior), n (%) 4 (2.58%)
Temporo-basal, n (%) 1 (0.64%)
JTO, n (%) 2 (1.27%)
Insular 10 (6.43%)
Insular, n (%) 9 (5.73%)
Insular-frontal (Predom. Ins), n (%) 1 (0.64%)
Parietal 17 (10.8%)
Parietal, n (%) 14 (8.92%)
Parieto-insular (Predom,P), n (%) 2 (1.27%)
Parieto-temporal (Predom,P, n (%) 1 (0.64)
Tumor radiological characteristics
Presurgical volume, cm3 53.18 (46.73)
Postsurgical volume, cm3 5.54 (7.88)
Extent of Resection (%) 92.28%
Total resection, n (%) 44 (28.02%)
Subtotal resection, n (%) 80 (50.96%)
Partial resection, n (%) 33 (21.02%)
Tumor Histopathological characteristics
Astrocytoma, IDH mutated, n (%) 85 (54%)
Astrocytoma, IDH wild type, n (%) 25 (16%)
Oligodendroglioma IDH mutated 1p19qcodeleted, n (%) 47 (30%)
Oncological treatment
Previous chemotherapy, n (%) 11 (7%)